Insights into Pediatric Survivorship for the HCP Treating Blood Cancers

Kevin C. Oeffinger, MD, FASCO, Duke University Medical Center, Durham, NC

























Recorded on June 9, 2022











Kevin C. Oeffinger, MD, FASCO

Director, Duke Cancer Institute (DCI) Center for Onco-Primary Care

Director, DCI Supportive Care and Survivorship Center

Professor of Medicine, Division of Medical Oncology

Department of Medicine

Duke University Medical Center

Durham, NC





Children diagnosed with cancer are a heterogenous population experiencing different cancer diagnoses and therapies. Each journey presents its own physical, emotional, and psychosocial challenges that healthcare providers need to be attentive to. In this episode, Dr. Kevin Oeffinger, from Duke University in Durham, North Carolina, joins us to discuss the history of pediatric survivorship, physical, long-term, and late effects of treatment, including fertility considerations, strategies to support the survivor through psychosocial and cognitive effects, following a survivorship care plan, symptom monitoring, follow-up care, and so much more. Tune in to this important conversation today!











This podcast episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Pharmacyclics LLC, An AbbVie Company and Janssen Biotech, Inc.